Reviva Pharmaceuticals Holdings, Inc.

NASDAQ:RVPH

1.91 (USD) • At close January 24, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q2
Revenue 00000000000000000000000000
Cost of Revenue 0000000000000000.3520.5260.26500.1660.0940.07100.0790.0020
Gross Profit 000000000000000-0.352-0.526-0.2650-0.166-0.094-0.0710-0.079-0.0020
Gross Profit Ratio 00000000000000000000000000
Reseach & Development Expenses 6.8585.5845.7848.4768.7178.9915.2356.2972.3064.5145.832.6631.4230.3740.3910.2950.0010.0360.2710000.032000
General & Administrative Expenses 1.6042.5452.1381.5121.9923.0791.5011.4771.2571.0051.621.3021.0531.4161.4810.5270.5110.7410.3470000.139000
Selling & Marketing Expenses 00000000000000000000000000
SG&A 1.6042.5452.1381.5121.9923.0791.5011.4771.2571.0051.621.3021.0531.4161.4810.5270.5110.7410.3470000.139000.013
Other Expenses 00000.005-0-0.0140000000000000000000
Operating Expenses 8.4638.137.9229.98810.70912.0716.7367.7743.5635.5197.453.9652.4771.791.8720.5270.5120.7770.6180000.171000.013
Operating Income -8.463-8.13-7.922-9.988-10.709-12.071-6.736-7.774-3.563-5.519-7.45-3.965-2.477-1.79-1.872-0.527-0.512-0.777-0.618-0.166-0.094-0.071-0.171-0.079-0.002-0.013
Operating Income Ratio 00000000000000000000000000
Total Other Income Expenses Net 0.0970.2770.4960.260.144-0.4560.136-0.3360.050.1860.0890.2780.20.1890.9230.523-0.146-0.074-0.130.3030.3680.41-0.1440.3420.020
Income Before Tax -8.366-7.853-7.426-9.729-10.479-12.436-6.6-8.11-3.513-5.334-7.361-3.685-2.277-1.605-0.949-1.524-0.659-0.851-0.7480.1370.2740.338-0.3140.2630.018-0.013
Income Before Tax Ratio 00000000000000000000000000
Income Tax Expense 00.0070.007-0.0050.0120.0060.0030.0080.0020.0070.004-0.2740.0020.0040.001-0.0010.0010.0250.0010000.001000
Net Income -8.366-7.86-7.434-9.724-10.491-12.443-6.603-8.118-3.515-5.341-7.365-3.685-2.279-1.608-0.949-1.524-0.659-0.851-0.7490.1370.2740.338-0.3150.2630.018-0.013
Net Income Ratio 00000000000000000000000000
EPS -0.25-0.26-0.250-0.44-0.55-0.3-0.42-0.18-0.29-0.4-0.29-0.12-0.12-0.1-0.17-0.24-0.31-0.270.0520.110.13-0.0170.10.012-0.01
EPS Diluted -0.25-0.26-0.250-0.44-0.55-0.3-0.42-0.18-0.29-0.4-0.29-0.12-0.12-0.1-0.17-0.24-0.31-0.270.0520.110.13-0.0170.10.012-0.01
EBITDA 0-7.847-7.423-9.387-10.612-11.967-6.603-7.312-3.563-5.698-7.539-3.965-2.477-1.79-1.872-0.446-0.512-0.752-0.618-0.166-0.094-0.071-0.171-0.079-0.002-0.013
EBITDA Ratio 00000000000000000000000000